NASDAQ:GYRO Gyrodyne (GYRO) Stock Price, News & Analysis $5.63 -0.07 (-1.28%) Closing price 07/24/2026 03:58 PM EasternExtended Trading$5.62 0.00 (-0.04%) As of 07/24/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About Gyrodyne Stock (NASDAQ:GYRO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Gyrodyne alerts:Sign Up Key Stats Today's Range$5.70▼$5.7150-Day Range$5.63▼$7.6952-Week Range$5.70▼$12.00Volume6,344 shsAverage Volume912 shsMarket Capitalization$12.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Gyrodyne Company of America, Inc. is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations. The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island. This portfolio features a diversified mix of multi-tenant buildings that house outpatient services, rehabilitation centers and specialty laboratories. Gyrodyne’s strategic approach involves acquiring under-utilized or newly developed properties, investing in targeted capital improvements, and securing long-term leases with creditworthy tenants. Through hands-on property management and an emphasis on tenant retention, the firm aims to enhance asset value and maintain a resilient revenue base. Originally founded in 1959 and initially engaged in rotorcraft design and manufacturing, Gyrodyne transitioned to a real estate-focused business in the late 1980s. Over the decades, the company has built deep ties to the greater Long Island region, leveraging local market knowledge and zoning expertise to support its development initiatives. Led by an experienced management team and overseen by a board of directors with backgrounds in real estate and healthcare industries, Gyrodyne continues to pursue opportunities that align with its mission of delivering high-quality, medically oriented real estate solutions to its tenant community.AI Generated. May Contain Errors. Read More Receive GYRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GYRO Stock News HeadlinesGyrodyne Insider Trading Activity | NASDAQ:GYRO | BenzingaJuly 8, 2026 | benzinga.comGyrodyne amends Flowerfield property sale agreement with B2K SmithtownJanuary 14, 2026 | investing.comDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.July 26 at 1:00 AM | Porter & Company (Ad)Gyrodyne enters agreement with Star Equity FundOctober 17, 2025 | msn.comGyrodyne Announces Agreement with Star Equity FundOctober 17, 2025 | globenewswire.comGyrodyne trading halted, news pendingAugust 6, 2025 | msn.comGYRODYNE, LLC ANNOUNCES AGREEMENT TO SELL 49-ACRE PARCEL IN SMITHTOWN, NEW YORK AS PART OF STRATEGIC LIQUIDATION PLANAugust 4, 2025 | globenewswire.comHere's How Much Horsepower Boeing's T50 Engines Can HaveJuly 13, 2025 | msn.comSee More Headlines GYRO Stock Analysis - Frequently Asked Questions How have GYRO shares performed this year? Gyrodyne 's stock was trading at $9.11 at the beginning of 2026. Since then, GYRO shares have decreased by 38.2% and is now trading at $5.6270. How do I buy shares of Gyrodyne ? Shares of GYRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Gyrodyne own? Based on aggregate information from My MarketBeat watchlists, some other companies that Gyrodyne investors own include Meta Platforms (META), Astrotech (ASTC), Athersys (ATHX) and Company Calendar Today7/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 GYRO's financial health is in the Red zone, according to TradeSmith. GYRO has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry REAL ESTATE OPS Sub-IndustryDiversified REITs Current SymbolNASDAQ:GYRO CIK1589061 Webwww.gyrodyne.com Phone(631) 584-5400Fax631-584-7075Employees6Year Founded1946Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,200,000Free Float1,933,000Market Cap$12.38 million OptionableNot Optionable Beta0.51 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:GYRO) was last updated on 7/26/2026 by MarketBeat.com Staff. From Our PartnersThe comeback story of the century (ticker inside)In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...InvestorPlace | SponsoredUniversal basic income is not impossible. It exist (kind of)Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis tiny piece of glass could be bigger than GPUsJensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...Brownstone Research | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey’re still buying the wrong AI stocksTesla and Alphabet just tumbled, and many investors concluded AI is over. It isn't - the easy AI trade may be....The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyrodyne , LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyrodyne With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
